TY - STD TI - NACA. (2017) ‘National Strategic Framework on HIV and AIDS: 2017–2020. ID - ref1 ER - TY - STD TI - Insulin resistance, hyperglycemia and diabetes on antiretroviral therapy. Guide for HIV/AIDS clinical care. Section 6: Comorbidities, coinfections and complications. https://aidsetc.org/guide/insulin-resistance-hyperglycaemia. UR - https://aidsetc.org/guide/insulin-resistance-hyperglycaemia ID - ref2 ER - TY - JOUR AU - Kalra, S. AU - Kalra, B. AU - Agrawal, N. AU - Unnikrishnan, A. G. PY - 2011 DA - 2011// TI - Understanding diabetes in patients with HIV/AIS JO - Diabetol metab syndr VL - 3 UR - https://doi.org/10.1186/1758-5996-3-2 DO - 10.1186/1758-5996-3-2 ID - Kalra2011 ER - TY - JOUR AU - Spagnuolo, M. I. AU - Liguoro, I. AU - Guarino, A. PY - 2014 DA - 2014// TI - Metabolic disorders in HIV-infected children JO - J Metabolic Synd VL - 3 ID - Spagnuolo2014 ER - TY - JOUR AU - Umpathi, K. K. AU - Thavamani, A. AU - Al-Kindi, S. PY - 2019 DA - 2019// TI - Pre-diabetes in children and adolescents in the United States: Prevalence estimates and comorbidities - a population analysis JO - J Pediatr Endocrinol Metab VL - 32 UR - https://doi.org/10.1515/jpem-2018-0374 DO - 10.1515/jpem-2018-0374 ID - Umpathi2019 ER - TY - STD TI - Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016; 355. https://doi.org/10.1136/bmj.i5953. ID - ref6 ER - TY - JOUR AU - Brown, T. T. AU - Cole, S. R. AU - Li, X. AU - Kingsley, L. A. AU - Palella, F. J. PY - 2005 DA - 2005// TI - Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicentre AIDS Cohort Study JO - Arch Intern Med VL - 165 UR - https://doi.org/10.1001/archinte.165.10.1179 DO - 10.1001/archinte.165.10.1179 ID - Brown2005 ER - TY - STD TI - Santiprabhob J, Tanchaweng S, Maturapat S, Maleesatharn A, Lermankul W, Sricharoenchai S, et al. Metabolic disorders in HIV-infected adolescents receiving protease inhibitors. Biomed Research International. 2017:2017:7481597. ID - ref8 ER - TY - STD TI - Vincento de T. Age-related impairment of pancreatic beta-cell function: Pathophysiological and cellular mechanisms. Front Endocrinol (Lausanne). 2014;5:138. ID - ref9 ER - TY - JOUR AU - Nguyen, Q. C. AU - Srinivasan, S. R. PY - 2010 DA - 2010// TI - Fasting plasma glucose levels within the normoglycemic range in childhood as a predictor of prediabetes and type 2 diabetes in adulthood. The Bogalusa heart study JO - Arch pedatr Adolesc Med VL - 164 ID - Nguyen2010 ER - TY - JOUR AU - Janghorbani, M. AU - Amini, M. PY - 2011 DA - 2011// TI - Normal fating plasma glucose and risk of prediabetes and type 2 diabetes: The Isfahan diabetes prevention study JO - Rev Diabet Stud VL - 8 UR - https://doi.org/10.1900/RDS.2011.8.490 DO - 10.1900/RDS.2011.8.490 ID - Janghorbani2011 ER - TY - JOUR AU - Wang, G. AU - Arguelles, L. AU - Liu, R. AU - Zhang, S. AU - Brickman, W. J. AU - Hong, X. PY - 2011 DA - 2011// TI - Tracking blood glucose and predicting prediabetes in Chinese children and adolescents: A prospective twin study JO - PLoS One. VL - 6 UR - https://doi.org/10.1371/journal.pone.0028573 DO - 10.1371/journal.pone.0028573 ID - Wang2011 ER - TY - JOUR AU - Shankalala, P. AU - Choolwe, J. AU - Samuel, B. AU - Michael, V. AU - Patrick, K. AU - Charles, M. PY - 2017 DA - 2017// TI - Risk factors for impaired glucose or diabetes among HIV infected patients on ART in the Copperbelt Province of Zambia JO - J Diabetes Metab Disord VL - 16 UR - https://doi.org/10.1186/s40200-017-0310-x DO - 10.1186/s40200-017-0310-x ID - Shankalala2017 ER - TY - JOUR AU - Duncan, A. D. AU - Goff, L. M. AU - Peters, B. S. PY - 2018 DA - 2018// TI - Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study JO - PLoS ONE VL - 13 UR - https://doi.org/10.1371/journal.pone.0194199 DO - 10.1371/journal.pone.0194199 ID - Duncan2018 ER - TY - JOUR AU - Solomon, M. A. AU - Assefa, G. AU - Solomon, F. AU - Mulugeta, B. AU - Abayneh, G. D. AU - Nebiyu, M. PY - 2016 DA - 2016// TI - Diabetes mellitus among HIV-infected individuals in follow-up care at university of Gondar Hospital, Northwest Ethiopia JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2016-011175 DO - 10.1136/bmjopen-2016-011175 ID - Solomon2016 ER - TY - JOUR AU - Rao, M. N. AU - Lee, G. A. AU - Grunfeld, C. PY - 2006 DA - 2006// TI - Metabolic abnormalities associated with the use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors JO - Am J Infect Dis VL - 2 UR - https://doi.org/10.3844/ajidsp.2006.159.166 DO - 10.3844/ajidsp.2006.159.166 ID - Rao2006 ER - TY - BOOK AU - Lumpkin, M. M. PY - 1997 DA - 1997// TI - Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus (HIV), FDA Public Advisory PB - DCUS Food and drug Administration CY - Washington ID - Lumpkin1997 ER - TY - JOUR AU - Dever, L. L. AU - Oruwari, P. A. AU - Figueroa, W. E. AU - O’Donovan, C. A. AU - Eng, R. H. PY - 2000 DA - 2000// TI - Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population JO - Ann Pharmacother VL - 34 UR - https://doi.org/10.1345/aph.19231 DO - 10.1345/aph.19231 ID - Dever2000 ER - TY - JOUR AU - Tsiodras, S. AU - Mantzoros, C. AU - Hammer, S. AU - Samore, M. PY - 2000 DA - 2000// TI - Effects of Protease inhibitors on hyperglycemia, hyperlipidemia and lipodystrophy. A 5-year cohort study JO - Arch Intern Med VL - 160 UR - https://doi.org/10.1001/archinte.160.13.2050 DO - 10.1001/archinte.160.13.2050 ID - Tsiodras2000 ER - TY - JOUR AU - Carr, A. AU - Samaras, K. AU - Thorisdottir, A. AU - Kaufmann, G. R. AU - Chisholm, D. J. AU - Cooper, D. A. PY - 1999 DA - 1999// TI - Diagnosis, prediction, an natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: a cohort study JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)08468-2 DO - 10.1016/S0140-6736(98)08468-2 ID - Carr1999 ER - TY - JOUR AU - Saves, M. AU - Francois, R. AU - Jacqueline, C. AU - Rozenbaum, W. AU - Ragnaud, J. -. M. AU - Perronne, C. PY - 2002 DA - 2002// TI - Factors related to lipodystrophy and metabolic alterations in patients with Human immunodeficiency virus infection receiving highly active antiretroviral therapy JO - Clin Infec Dis VL - 34 UR - https://doi.org/10.1086/339866 DO - 10.1086/339866 ID - Saves2002 ER - TY - JOUR AU - Koster, J. C. AU - Remedi, M. S. AU - Qiu, H. AU - Nichols, C. G. AU - Hruz, P. W. PY - 2003 DA - 2003// TI - HIV protease inhibitors acutely impair glucose-stimulated insulin release JO - Diabetes VL - 52 UR - https://doi.org/10.2337/diabetes.52.7.1695 DO - 10.2337/diabetes.52.7.1695 ID - Koster2003 ER - TY - STD TI - Dufer M, Neye Y, Krippeit-Drews P, Drews G. Direct interference of HIV protease inhibitors with pancreatic beta-cell function. Naunyn Schmiedebergs Arch Pharmacol. 2004;369:583–90. ID - ref23 ER - TY - JOUR AU - Martinez, E. AU - Conget, I. AU - Loranzo, L. AU - Casamitjana, R. AU - Gatell, J. M. PY - 1999 DA - 1999// TI - Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine JO - AIDS VL - 7 UR - https://doi.org/10.1097/00002030-199905070-00009 DO - 10.1097/00002030-199905070-00009 ID - Martinez1999 ER - TY - JOUR AU - Woerle, H. J. AU - Mariuz, P. R. AU - Meyer, C. AU - Reichman, R. C. AU - Popa, E. M. AU - Dostou, J. M. PY - 2003 DA - 2003// TI - Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens JO - Diabetes VL - 52 UR - https://doi.org/10.2337/diabetes.52.4.918 DO - 10.2337/diabetes.52.4.918 ID - Woerle2003 ER - TY - JOUR AU - Ige, O. O. AU - Yilgwan, C. S. AU - Ebonyi, A. O. AU - Adah, R. AU - Adedeji, I. AU - Yiltok, E. S. PY - 2017 DA - 2017// TI - Serum lipid and glucose profiles in HIV-positive Nigerian children JO - J Virus Erad VL - 3 UR - https://doi.org/10.1016/S2055-6640(20)30335-6 DO - 10.1016/S2055-6640(20)30335-6 ID - Ige2017 ER - TY - STD TI - Chantry CJ, Hughes MD, Alvero C, Cervia JS, Meyer WA 3. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy. Pediatrics. 2008;122:e129-38. rd et al. ID - ref27 ER - TY - JOUR AU - Vigano, A. AU - Brambilla, P. AU - Pattarino, G. AU - Stucchi, S. AU - Fasan, S. AU - Raimondi, C. PY - 2009 DA - 2009// TI - Long-term evaluation of glucose homeostatsis in a cohort of HAART-treated HIV-infected children. A longitudinal, observational cohort study JO - Clin Drug Invest VL - 29 UR - https://doi.org/10.2165/0044011-200929020-00004 DO - 10.2165/0044011-200929020-00004 ID - Vigano2009 ER - TY - JOUR AU - Dejkhamron, P. AU - Unachak, K. AU - Aurpibul, L. AU - Sirisanthana, V. PY - 2014 DA - 2014// TI - Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinaviréritonavir-based highly active antiretroviral therapy JO - J Pediatr Endocrinol metab VL - 27 UR - https://doi.org/10.1515/jpem-2013-0253 DO - 10.1515/jpem-2013-0253 ID - Dejkhamron2014 ER - TY - JOUR AU - Ngondi, J. AU - Mbouobda, H. D. AU - Fonkoua, M. AU - Nouemsi, A. P. K. AU - Oben, J. PY - 2007 DA - 2007// TI - The long-term effect of different combination therapies on glucose metabolism in HIV/AIDS subjects in Cameroon JO - J Med Sci VL - 7 UR - https://doi.org/10.3923/jms.2007.609.614 DO - 10.3923/jms.2007.609.614 ID - Ngondi2007 ER - TY - JOUR AU - Brown, T. T. AU - Tassiopoulos, K. AU - Bosch, R. J. AU - Shikuma, C. AU - McComsey, G. A. PY - 2010 DA - 2010// TI - Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc10-0633 DO - 10.2337/dc10-0633 ID - Brown2010 ER -